T1	Participants 254 290	patients with respiratory allergies.
T2	Participants 536 640	Adult and pediatric patients with allergic rhinoconjunctivitis and/or asthma were included in the study.
T3	Participants 641 653	Ten subjects
T4	Participants 710 730	Forty-three subjects
T5	Participants 1354 1389	patients with respiratory allergies
